BRAF Controls the Effects of Metformin on Neuroblast Cell Divisions in C. elegans

Metformin has demonstrated substantial potential for use in cancer treatments. Liver kinase B (LKB)-AMP-activated protein kinase (AMPK) and mTOR are reported to be the main targets of metformin in relation to its ability to prevent cancer cell proliferation. However, the role of metformin in the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Zhi, Ji, Shaoping, Zheng, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795703/
https://www.ncbi.nlm.nih.gov/pubmed/33375360
http://dx.doi.org/10.3390/ijms22010178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795703/
https://www.ncbi.nlm.nih.gov/pubmed/33375360
http://dx.doi.org/10.3390/ijms22010178

Ejemplares similares